Your healthcare provider will do blood tests to check your bloodcell counts: WHAT IS LYNPARZA? LYNPARZA is a prescription medicine used to treat adultswho have: advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) or acquired...
Use of blood tumour markers in the detection of recurrent breast cancer. Breast 1998; 7: 187-9.Molina, R. & Gion, M. (1998) Use of blood tumour markers in the detection of recurrent breast cancer. The Breast 7, 187-189.Molina R, Gion M. Use of blood tumour markers in the ...
Close Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly. Email address Sign up I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy....
neoantigens derived from recurrent oncogenic mutations have the advantage that a single TCR with off-the-shelf availability could target larger patient groups. Although shared mutations resulting in neoantigens presented on frequently expressed HLA alleles are rare in solid cancer, promising results were ...
- 《Cancer Research》 被引量: 222发表: 1988年 Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission Activation and expansion in ...
Blood analyses were taken and INNO-LiPA HPV Genotyping Extra® test (FujiReBio) was used to determine the human papillo- mavirus type. The patient population consisted of n = 24 patients (11 female and 13 male). Patients younger than 12 years (n = 4, 3 female and 1 male) suffered ...
“Karnofsky performance equal to or above 60% and adequate bone marrow and organ function,” Wolff said. Although concomitant use of corticosteroids (65%), calcineurin inhibitors (28%), and mTOR inhibitors (12%) was permitted, it was not required. No additional systemic treatment for cGVHD ...
LENVIMA inhibits other kinases that have been implicated in pathogenic angiogenesis, tumor growth, and cancer progression in addition to their normal cellular functions, including fibroblast growth factor (FGF) receptors FGFR1-4, the pl...
does not infect normal bone marrow-derived cells2,42, but recent studies show that even some blood cancers are susceptible to G47∆ (refs.43,44). Further, G47Δ has been shown to have augmented efficacy when used in combination with immune checkpoint inhibitors38,45,46. We will pursue ...
Hayakawa, F. et al. Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group.Blood Cancer J.4, e252 (2014). ...